While few side effects are reported with regular use, it's always best to consult a healthcare provider before starting any new supplement, especially if opting for IV glutathione
The most cited clinical trial is the open-label MASLD pilot by Honda et al., in which 300 mg/day oral glutathione for 4 months reduced ALT and hepatic steatosis in 29 patients, but without histological or survival data and with no control arm (Honda et al., 2017)
Genetic background of taste perception, taste preferences, and its nutritional implications: a systematic review
Intravascular Ultrasound-Guided Versus Angiography-Guided Percutaneous Coronary Intervention In Unprotected Left Main Coronary Artery Disease The Optimal Trial
InfiniWell's BPC Probiotic pairs BPC with Akkermansia, a beneficial gut bacterium that helps balance the gut environment
For further questions or comments regarding how we handle your personal data, you can always contact us, either by email at [email protected] or by mail to any of the aforementioned postal addresses